Cargando…
A Dominant Negative Antisense Approach Targeting β-Catenin
There have been many attempts to unveil the therapeutic potential of antisense molecules during the last decade. Due to its specific role in canonical Wnt signalling, β-catenin is a potential target for an antisense-based antitumour therapy. In order to establish such a strategy with peptide nucleic...
Autores principales: | Vonbrüll, Matthias, Riegel, Elisabeth, Halter, Christian, Aigner, Michaela, Bock, Holger, Werner, Birgit, Lindhorst, Thomas, Czerny, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918491/ https://www.ncbi.nlm.nih.gov/pubmed/29524201 http://dx.doi.org/10.1007/s12033-018-0058-7 |
Ejemplares similares
-
The function of tcf3 in medaka embryos: efficient knockdown with pePNAs
por: Doenz, Gerlinde, et al.
Publicado: (2018) -
Side chain modified peptide nucleic acids (PNA) for knock-down of six3 in medaka embryos
por: Dorn, Sebastian, et al.
Publicado: (2012) -
Wnt/Axin1/β-Catenin Signaling Regulates Asymmetric Nodal Activation, Elaboration, and Concordance of CNS Asymmetries
por: Carl, Matthias, et al.
Publicado: (2007) -
Targeting Wnt/β-Catenin Activated Cells with Dominant-Negative N-cadherin to Reduce Neointima Formation
por: Hulin-Curtis, Sarah, et al.
Publicado: (2017) -
Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative β-catenin
por: Kennedy, Karen AM, et al.
Publicado: (2009)